China’s move to restrict the export of fentanyl precursors might have far-reaching consequences well beyond pharmaceutical and law enforcement circles. The cutdown, part of a trade deal reached between Xi Jinping and Donald Trump last month, represents a thaw in U.S.–China relations that could brighten the outlook for China-focused and emerging-market ETFs.
Beijing added more than a dozen synthetic opioid ingredients to its list of controlled exports to the U.S., Mexico, and Canada – an apparent attempt to meet Washington halfway on curbing the fentanyl crisis. The Trump administration also cut tariffs on Chinese goods in half to 10%, effective Monday, easing a key trade irritant. A reciprocal suspension of port fees and maritime probes between the two countries also points to broader cooperation in stabilizing trade flows.
